Monte Rosa Therapeutics (GLUE) is the lead sponsor of 2 active clinical trials listed on ClinicalTrials.gov[3], including 1 Phase 2[1], 2 Phase 1[2].
GLUE has 2 Form 4 insider filings recorded at the SEC in the past 30 days[4].
Monte Rosa Therapeutics (GLUE) is the lead sponsor of 2 active clinical trials listed on ClinicalTrials.gov[3], including 1 Phase 2[1], 2 Phase 1[2].
GLUE has 2 Form 4 insider filings recorded at the SEC in the past 30 days[4].